From GIVING to IMPACT: Venture Philanthropy.

Venture philanthropy is giving that works. It’s bold, structured, and built to solve real problems—not just fund them.

Venture philanthropy (VP) offers a different path. It combines the heart of philanthropy with the tools of business. It’s not about making money—but it is about making change. Whether you’re a foundation leader, a donor, a social entrepreneur, or someone who just wants to do good differently, this guide is for you.

In traditional philanthropy, you give a grant. The money is usually unrestricted. The organization thanks you, runs its program, and maybe sends you an annual report. It’s well-intentioned—but sometimes it’s hard to know if your donation really made a difference.

In venture capital, you invest in a startup. You check their business plan, negotiate terms, expect results, and if things go well, you get a return. The process is rigorous, data-driven, and aimed at success.

Venture philanthropy takes the best of both. You fund organizations or projects that are tackling big social problems—but instead of walking away, you stay engaged. You measure progress. You fund in stages. You offer advice, tools, and support. And if there’s a financial return (like a loan repaid or an equity stake), you reinvest it in your next impact project.

ABOUT THE AUTHOR

Professor James A. LEVINE, MD PhD

Dr. Levine, President Fondation Ipsen, has three decades of experience in the healthcare sector principally at Mayo Clinic. For the last 6 years he has been President of Fondation Ipsen, an international science foundation focused on biotech innovation in Rare Diseases. A physician and scientist, James has published more than 200 articles, six papers in Science and Nature plus articles in journals such as, the New England Journal of Medicine, Lancet and JAMA. He has written four books published in 19 languages in 37 countries. His business training, focused on entrepreneurship, was from Harvard Business School. With a background in wearable technologies, data gathering and data analytics, and with more than 100 patents and trademarks, Levine helped found 35 companies. He was the Innovator of the Year in the state of Minnesota, the World Trade Fair and NASA. Under the Mayo Clinic NEAT Trademarks, Levine’s team delivered scalable health solutions to 72 US corporations. A great deal of James’ work focusses on biotech development, scalable health solutions and business opportunities in underserved regions in the United States, France and low/middle countries such as the Democratic Republic of Congo, Cote d’Ivoire, Afghanistan, Jamaica, Asia, Kenya and India. Consulting to the President of the United States, the US State Department, US Army and internationally, James in 2018 was awarded the President’s Medal for promoting social embeddedness. 300 million people live with rare diseases without effective cures. Sustainable solutions require the efficient use of capital to optimize biotechnology companies, maximize impact and minimize suffering.